11. Obesity (1) - insulin resistance Flashcards
(43 cards)
Difference between peripheral and central obesity
Peripheral
- subcutaneous fat
- excess below the waist (hips, butt, thighs)
- NOT likely a major health risk factor
Central (Abdominal) Obesity
- visceral fat (surrounds heart, liver, intestines, kidney)
- very strong predictor of health risk
- pro-inflammatory, IR, diabetes risk, heart disease
Easiest way to measure Visceral Fat
- male and female measure
- other ways to measure
waist circumference
- men > 102 cm
- women > 88 cm
others
- MRI and CT
- $$$
key independent predictor of all cause mortality
- some basic measurements
visceral fat
- 0.5kg normal
- 1.0kg 2 fold higher risk for mortality
Why is increased visceral fat a potential health risk?
associated with
- increased lipolysis
- increased plasma FFAs
- increased secretory products (adipokines -> inflammatory mediator)
- *increased insulin resistance**
- less glucose uptake into cells
- increased blood glucose levels
what do adipokines do?
inflammatory mediator
adipo = fat kines = signal molecules
what is insulin resistance?
- how does it impair normal response
- result in skeletal muscle
inability of insulin to produce a “normal” response at a given tissue
- defect in insulin signalling leads to impaired GLUT4 translocation to membrane
- reduced insulin stimulated glucose uptake in muscle
hyperinsulinemia definition
- high levels of insulin in the blood
- result from over production of insulin in the pancreas in order to compensate for insulin resistance
stages in the development of T2D
- is it reversible?
1) impaired glucose tolerance
- obesity causes insulin resistance and impaired glucose tolerance directly
- hyperinsulinemia -> over production of insulin to compensate for resistance
2) early diabetes
- decreased insulin secretion
- result from beta cell defect
- cells exhausted and damaged from overproduction
3) late diabetes
- beta cells fail
- no insulin produced
** can be reversible with lifestyle change depending on stage -> only lived with it for a few years
clinal signs of T2D
Glucose
- fasting hyperglycemia (>7mM)
Insulin
- dependent on stage of diabetes
- impaired gluc tolerance -> high levels
- early diabetes -> low levels
- late diabetes -> no insulin
clinical tests used to assess diabetes
1) oral glucose tolerance test
2) euglycemic / hyperinsulinemic clamp
diabetes NOT associated with diabetes
Type 1 diabetes
(aka juvenile or insulin-dependent diabetes)
- autoimmune disease
- children
- genetics or exposure to certain virusis
- no cure (irreversible)
OGTT
Oral Glucose Tolerance Test
- measures acute metabolic response to glucose ingestion at whole body level
Method
- 75g glucose beverage (Trutol)
- measured 2hrs after ingestion (should return to near normal levels)
OGTT clinical diagnostic measurements
Diagnostic criteria after 2hrs from ingestion
- 7.8mM = impaired glucose tolerance
- 11.1mM = T2D
OGTT response to “glucose” in lean, obese and T2D
Normal
- fasting ~4-5mM
- peak at 1hr ~6-7mM
- return to normal after 2hr
- obese without diabetes similar response*
T2D
- impaired fasting glucose ~6-7mM
- huge spike glucose response (peak at 1hr)
- diagnosed with disease at 11.1mM after 2hr
- > 3hrs to return to normal
OGTT response to “insulin” in lean, obese and T2D
Fasting insulin - similar for all health states (~10mM but highly variable between individuals)
Lean (healthy)
- peak after 30min ~40mM
- slow/steady decline
Obese (healthy)
- “huge”peak after 30min ~90mM (hyperinsulinemia)
- indicates insulin resistance
- pancreas works hard not to become diabetic
Obese T2D
- peak after 1.5hr* (much longer)
- peak response between obese and lean ~50-60mM
- pancreas exhausted, fewer cells to secrete amount needed
Lean T2D
- little to no response
- similar to type 1
- pancreas likely severely damaged
Euglycemic definition
normal blood glucose level
Gold standard for measuring whole body insulin sensitivity
hyperinsulinemia euglycemic clamp
- measures responsiveness to insulin
- used in lab, not clinically ($$$)
hyperinsulinemic euglycemic clamp procedure
raise insulin levels to supra-physiological levels via infusion
- monitor glucose infusion rate (GIR) required to maintain normal/steady blood glucose levels
- check every 5-10min
hyperinsulinemic euglycemic clamp measures
High GIR
- >7.5mg/min = very insulin sensitive (athletes)
GIR definition
glucose infusion rate
- measured during hyperinsulinemic euglycemic clamp
- high amounts of insulin infused
- muscle responds by absorbing resting blood glucose
- glucose infused at a certain rate to maintain normal glucose levels (euglycemia)
Effect of elevated levels of free fatty acids on insulin resistace
can induce insulin resistance “in only 4-6hrs”
Fatty acid uptake in lean, obese and T2D
- palmate transport rate into muscle
HUGE improvement in FA uptake ability in obese and T2D patients (compared to lean and overweight)
How does fatty acid uptake improve in obese and T2D patients?
FAT/CD36 “redistribution” to plasma membrane
- huge increase at the plasma membrane
- NO CHANGE in whole muscle content (homogenate)
intergral membrane protein involved in FA transport
FAT/CD36
fatty acid translocase / cluster of distribution 36